Ainnocence Shows Its Protein Foundation Model Improves Antibody-Antigen Affinity Ranking by 28%

Ainnocence's protein foundation model, AINN-P1, improves antibody-antigen affinity ranking by 28% using sequence data alone, without requiring structural information or multiple sequence alignments. This advancement reduces training time significantly and boosts accuracy, enabling rapid and reproducible antibody affinity maturation in drug discovery.

This Wire brief sits within Fusion42's coverage of Biotech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.